Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 9427901.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The efficacy of dexamethasone therapy for primary respiratory syncytial virus bronchiolitis was studied in a double-blind placebo design in 29 previously healthy infants (median age, 194 days). No significant differences were found between the groups in evolution of respiratory rate, oxygen saturation, clinical score, or pulmonary function tests on day 3.
Medical subject headings
- Bronchiolitis, Viral
- Dexamethasone
- Glucocorticoids
- Respiratory Syncytial Virus Infections
- Respiratory Syncytial Virus, Human